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Abstract 
Endo-derived nitric oxide (NO) is synthesized from L-arginine by endothelium nitric oxide synthase (eNOS). Since reduced 
NO synthesis has been implicated in the development of coronary atherosclerosis; we hypothesized that polymorphisms of 
NOS gene might be associated with increased susceptibility to this disorder and coronary artery disease (CAD). We studied 
the 27 base pair tandem repeat polymorphism in intron4 of the endothelial nitric oxide synthase (eNOS) gene in 141 unre-
lated CAD patients with positive coronary angiograms in Shahid Rajaee Heart Hospital and 159 age matched control sub-
jects without a history of symptomatic CAD. The study protocol was approved by the Iran University of Medical Sciences 
Ethics Committee. The eNOS gene intron4a/b VNTR polymorphism was analyzed by polymerase chain reaction. The 
plasma lipids levels and other risk factors were also determined. The genotype frequencies for eNOS4b/b, eNOS4a/b and 
eNOS4a/a were 68.8, 29.1 and 2.1% in CAD subjects, and 81, 18.4 and 0.6 % in control subjects, respectively. The geno-
type frequencies differed significantly between the two groups (χ²= 6.38 P= 0.041). The frequency of the allele was 16.7% 
in CAD subjects and 9.8% in control subjects and was significantly higher in the patients (χ²= 6.18 P= 0.013, odds ra-
tio=1.84). Plasma lipids, except HDL-C were also remarkablely increased in CAD group. 
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Introduction 
Nitric Oxide is synthesized from L-arginine and 
molecular oxygen by a family of three enzymes, 
the nitric oxide synthase (NOS) (1, 2). NO is the 
most powerful endogenous vasodilator known. 
It can also inhibit the adhesion, aggregation and 
recruitment of platelets, vascular smooth muscle 
cells migration and growth, regulate some vessel-
platelet interactions and limits the oxidation of 
atherogenic low density lipoproteins (1). 
The inducible NOS is expressed in vessel walls 
and macrophages by certain cytokines and en-
dotoxins lipopolysaccharides in pathological con-
ditions (3). The constitutive neuronal NOS is 
expressed in the central and peripheral nervous 
systems as well as in macula densa of kidney. It 
plays important roles in physiological and patho-
physiological conditions (4). The constitutive en-
dothelial NO synthase (eNOS) is expressed in 
the endothelium, encoded by a 26 exon gene 
(NOS3) located on chromosome 7q35 to 36 with 
a total size of 21 kb and encodes an mRNA of 
4052 nucleotides (5, 6). 
The eNOS gene is expressionally and function-
ally regulated through multiple regulatory steps 
(7). Several allelic variants of eNOS gene have 
been identified and their association with hu-
man disease states studied. Moreover it has been 
shown that eNOS inhibition accelerates athero-
sclerosis in animal models and that abnormali-
ties in the endothelial NO pathway is present in 
human with atherosclerosis (8). 
The evidence suggest that NO may inhibit sev-
eral key steps in the atherosclerosis process and 
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that an alteration of NO production within the 
vascular endothelium could contribute to patho-
genesis of atherosclerosis (9). 
Several of eNOS gene polymorphisms have 
been reported as ‘susceptibility genes’ in various 
cardiovascular and pulmonary diseases (10). 
Yashimora et al. discovered a GT substitution in 
exon7 in codon 298 of the human eNOS gene, 
which alters the amino acid at this residue from 
glutamate to aspartate (11). A T786 mutation in 
the 5´- flanking region of eNOS gene, which 
reduces eNOS promoter activity in vitro, was 
associated with coronary spam in Japanese popu-
lation (12, 13). High numbers of CA repeat in 
intron 13 are also associated with an excess of 
risk of CAD (14). Among the reported polymor-
phisms of the eNOS gene, a significant associa-
tion of the 4a/b polymorphism in intron 4 of the 
eNOS gene with coronary artery disease (CAD) 
and hypertension has been reported too. Wang 
et al. detected an association between homozygos-
ity for the eNOS4a allele and an increased risk 
for CAD in current or ex-smokers (15). The vari-
able number of tandem repeat (VNTR) polymor-
phism located in intron 4 of eNOS (eNOS4b/a 
polymorphism) was reported to be significantly 
associated with plasma NOx concentration (16). 
In repeats of a 27-bp consensus sequence, two 
alleles, a common large allele and a smaller allele, 
were explored. The larger allele (eNOS4b al-
lele), designated ‘b-insertion’ has five tandem 
repeats, and the smaller allele (eNOS4a allele); 
‘a-deletion’ has four repeats (6). 
In the present study, we investigated the asso-
ciation between the occurrence of CAD and the 
intron4b/a polymorphism in Iranian patients. 
 
Materials and Methods 
Subjects     Patients recruited in this study 
(n=141; 100 males and 41 females) were an-
giographically identified (>50% stenosis affected 
at least one coronary vessel) as CAD in Shahid 
Rajaee Heart Hospital. The control group con-
sisted of 159 individuals (110 males and 49 
females), within the same age range as patients 
who had no history of heart disease, chest pain, 
diabetes, hypertension and general illness. All 
participants were interviewed and data on smok-
ing habitat, blood pressure, lipid profile and 
family history of CAD were recorded. Blood 
samples were obtained from all subjects after 
12 h fasting and placed in EDTA tubes and 
stored at -80 ºC until the time of assay. 
The study protocol was approved by Ethics 
Committee of Iran University of Medical Sciences. 
Biochemical Analysis     The serum concentra-
tions of triglyceride (TG), total cholesterol, 
LDL cholesterol (LDL-C) and HDL cholesterol 
(HDL-C) were measured by standard methods 
in the clinical laboratory of the hospital. 
DNA Analysis     Genomic DNA was extracted 
from peripheral blood leukocytes by standard 
methods. Two oligonucleotide primers (sense) 
5´-AGGCCCTATGGTAGTGCCTT-3´ and (an-
tisense) 5´- TCTCTTAGTGCTGTGGTCAC-3´ 
based on the flanking sequences of the VNTR 
in the ecNOS gene were used to amplify the 
corresponding DNA fragment by the polymerase 
chain reaction. The intron4 VNTR polymor-
phism of the eNOS gene was detected by method 
of Wang et al. (15) with some modifications. 
The reaction was performed in a 25-µl final 
volume and contained 25 pmol of each primer, 
0.2mmol of each deoxynucleoside triphosphate 
(Roche Germany), 1.5U Taq DNA polymerase 
(Fermentas Lithuania), 50mmol/L KCL, 2.5 
mmol/ L MgCl2, 10mmol/ L Tris-Hcl (PH= 8.3) 
and 400ng of genomic DNA according to the 
following protocol: initial denaturation at 94 ºC 
for 5 min; 35 cycles of denaturation at 94 ºC for 
30 s, annealing at 56 ºC for 1 min, and exten-
sion at 72 ºC for 1 min; and final extension at 
72 ºC for 7 min. The PCR products were sepa-
rated by electrophoresis on a 2% agarose gel 
and visualized by ethidum bromide staining. 
Statistical Analysis    All statistical analyses were 
performed with SPSS V. 11.5. Numeric data are 
presented as mean± SD. The differences be-
tween groups were examined by χ² test or an 
independent Student t-test when appropriate. 
Allele frequencies were estimated by the gene 
counting method. The frequencies of the alleles 
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and genotypes were compared between patient 
and control groups by the χ² test when appropri-
ate. The odds ratio (OR) and 95% confidence 
interval (CI) were also estimated. We performed 
multivariate logistic regression analysis to adjust 
risk factors, in which CAD was a dependent 
variable and independent variables were BMI   
(Body Mass Index), smoking, family history, 
SBP (Systolic Blood Pressure), DBP (Diastolic 
Blood Pressure), TG, total cholesterol level, LDL-
C, HDL-C, LDL-C/ HDL-C and eNOS genotype. 
 
Results  
The clinical characteristics of the study popula-
tion are shown in Table 1. Control subjects were 
matched to the case patients for gender and age. 
Although BMI and HDL-C showed no significant 
differences between the patients and the control 
subjects, systolic and diastolic blood pressure, 
triglyceride, total cholesterol, LDL-C and LDL-
C/HDL-C in patients were significantly higher.  
BMI and HDL-C did not differ between CAD 
patients and control subjects. Frequencies of 
smoking and family history in patients were 
higher than the controls. 
Two alleles of the VNTR in the human eNOS 
gene were detected in Iranian subjects (Fig. 1). 
One allele contained four of 27bp repeats 
(eNOS4a allele) giving rise to a PCR product of 
393 bp, whereas the other contained five of 
such repeats (eNOS4b allele), yielding a PCR 
product of 420 bp. The genotype frequencies of 
4b/a polymorphism in control subjects were 
81%. For b/b, 18.4% for b/a and 0.6% for a/a. 
On the other hand in CAD patients genotype 
frequencies were 68.79% for b/b, 29.08% for 
b/a and 2.13% for a/a (Table 2). ecNOS geno-
type was significantly associated with CAD 
(χ²= 6.38 P= 0.041).                
The frequencies of the a and b alleles were 16.7 
and 83.3% for CAD patients and; 9.8 and 90.2% 
for the control subjects, respectively, and dif-
fered significantly between two groups (χ²= 6.18, 
P= 0.013, odds ratio= 1.84). 
The logistic regression analysis revealed that SBP, 
DBP, smoking and family history were independ-
ent risk factors of CAD (P= 0.003, P= 0.053, 
P= 0.002 and P= 0.012, respectively), whereas 
4b/a genotype, total cholesterol, LDL-C and TG 
were not CAD independent risk factors. 
 
Table 1:  Clinical characteristics of the study population 
 
                                                  CAD Patients                     Controls                                    P  
             
 
NS 
NS 
χ ²=4.67  P=0.031 
χ ²=11.7  P=0.001 
P= 0.000 
P= 0.000 
P= 0.001 
P= 0.005 
P= 0.009 
NS 
P= 0.006 
158 
51.9±8.8 
27.2±18.2 
25.3 
21.5 
76.1± 6.7 
117± 14.9 
189.8± 32.8 
168.7± 86.8 
107.6± 33.7 
48.42± 11.8 
2.34± 0.88 
141 
53.1± 9.7 
27.4± 6.5 
36.88 
39.7 
84.8± 13.3 
130.1± 19.2 
204.99± 45.5 
200.6± 107.8 
118.5± 37.2 
46.43± 10.8 
2.63± 0.93 
No. of subjects 
Age (yr) 
BMI(kg/m²) 
Smoking (%) 
Family history (%) 
SBP (mmHg) 
DBP (mmHg) 
Cholesterol (mg/dl) 
TG (mg/dl) 
LDL-C (mg/dl) 
HDL-C (mg/dl) 
LDL-C/HDL-C 
NS= Non Significant 
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Table 2: Genotype and allele frequencies of 4b/a polymorphism of the ecNOS gene in CAD patients and controls 
 
 χ²          Pv       odds ratio(95% CI) Controls CAD patients  
6.38     0.041                            
 128(81) 97(68.8) 
 29(18.4) 41(29.1) 
 1(0.6) 3(2.1) 
 158 141 
 5.97    0.015             1.94   
 128(81) 97(68.8) 
 30(19) 44(31.2) 
 158 141 
   
6.18      0.013            1.84 90.2 83.3 
 9.8 16.7 
 100 100 
4b/a polymorphism 
b/b, n (%) 
b/a, n (%) 
a/a, n (%) 
total 
 
b/b, n (%) 
b/a + a/a, n (%) 
total 
allele 
b (%) 
a 
total 
 
                                                        1        2      3       4       5      6 
 
 
 
 
420bp 
400bp 
 
 
 
 
  
             
 
         393bp 
 
Fig. 1: Genotyping of the VNTR in intron4 of eNOS gene. The direct PCR product was separated by electrophoresis in 2% 
agarose gel and visualized by ethidum bromide staining. Lane 1; four-repeats homozygous, lane 2; four- and five – repeats 
heterozygous, lanes 3, 4 and 6; five- repeats homozygous. Lane 5 is the DNA marker and the band of 420bp indicates five 
repeats and the band of 393bp indicates four repeats of the 27bp.  
 
Discussion 
In addition to established risk factors, genetic 
risk factors may have important roles in the 
pathogenesis of coronary atherosclerosis and 
acute myocardial infraction. Using the approach 
of epidemiological studies it is possible to 
identify weak susceptibility genes in polygenic 
diseases like coronary heart disease (17). In the 
last decay, the potential link between an in-
creasing number of gene variants and coronary 
heart disease has been analyzed by several in-
vestigators. Due to the protective roles of nitric 
oxide against important events during athero-
genesis, the endothelial nitric oxide synthase 
gene has been identified as a further suscepti-
bility of coronary heart disease (18, 19). Ya-
shimura et al. described a point mutation of 
guanine to thymine at nucleotide 1917 in exon7 
of the eNOS gene that resulted in replacement 
of glutamic acid by aspartic acid at codon 296. 
In intron 4 of the eNOS gene a repeat polymor-
phism was identified; the larger allele, eNOS4b, 
contains five tandem 27-bp repeats, the smaller 
allele, eNOS4a, only four repeats (11). Later 
investigators describe other polymorphisms of 
eNOS gene in the 5' flanking and some introns. 
In the original study of Wang et al. there was in 
current smokers, but not in non smokers, an 
excess of homozygotes for the rare eNOS 4a 
allele in patients with severely stenosed arter-
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ies, compared with those with no or mild steno-
sis (15). In contrary, among Japanese popula-
tion, the eNOS 4a allele was an independent 
risk factor for myocardial infraction (MI) and 
with no differences between smokers and non-
smokers (20).  
Some other studies also identified an associa-
tion of the 27-bp repeat polymorphism with the 
risk of MI, CAD, EH (Essential Hypertension) 
(21, 22). Whereas other investigators did not 
detect a link to CAD, MI and EH (23-25). 
The reason for this discrepancy remains un-
clear. The discrepancy between these different 
studies may be attributable to various factors 
such as diagnostic criteria or race, for example 
the frequency of the four repeat allele was ap-
proximately 0.1 in our subjects is similar to 
previously reported in Japanese (0.1-0.13) (20, 
26), Spanish (0.13) (27) and Turkish (0.14) (28), 
but lower than the observed among the Cauca-
sian of Australia (0.17) (29) and African-Ameri-
cans (0.26-0.3) (30, 31). 
We showed that eNOS 4a/b polymorphism was 
associated with CAD in the Iranian population. 
Similarly, Matyar et al. found that the 4a/b 
VNTR polymorphism is associated with CAD 
in Southern Turkey (21) and also Kunnas et al. 
found that this polymorphism is associated with 
risk of CAD and MI in middle age men (30). In 
addition, Rao and Park found that eNOS 4a/b 
polymorphism is associated with CAD and acute 
coronary syndrome in African-American and 
Koreans respectively (31, 32). In contrast Garde-
mann did not detect a link in this polymorphism 
to CAD in Germans (23). 
By the multiple regression analysis, it became 
clear that SBP, DBP, family history and smok-
ing but not eNOS gene 4a/b polymorphism were 
independent risk factors of CAD. It was proba-
bly due to low number of samples. 
Our study had several limitations. The first was 
the lack of functional studies. Second, the 4a 
allele of the eNOS4a/b polymorphism had an 
estimated frequency of only 0.1, and the asso-
ciation between this polymorphism was based 
on only 4 individuals who were homozygous 
for this polymorphism. Thus, a larger sample 
should be examined to confirm the relation be-
tween this polymorphism and CAD. 
In conclusion in the present study we demon-
strated that eNOS4a/b polymorphism was asso-
ciated with CAD. But despite of other risk fac-
tors such as SBP, DBP, family history and smok-
ing, this polymorphism was not an independent 
risk factor however, larger sample sizes are nec-
essary for confirming the relationship between 
CAD and this variant.  
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